Dichloroacetophenones targeting at pyruvate dehydrogenase kinase 1 with improved selectivity and antiproliferative activity: Synthesis and structure-activity relationships

被引:17
|
作者
Zhang, Shao-Lin [1 ]
Yang, Zheng [1 ]
Hu, Xiaohui [2 ]
Tam, Kin Yip [1 ]
机构
[1] Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macao, Peoples R China
[2] Univ Macau, Fac Hlth Sci, Drug Dev Core, Taipa, Macao, Peoples R China
关键词
Pyruvate dehydrogenase kinase; Pyruvate dehydrogenase complex; Antiproliferative activity; Dichloroacetophenone; Kinase inhibition; CANCER-CELLS; LUNG-CANCER; INHIBITORS; METABOLISM; GROWTH; PDK1; PROLIFERATION; EXPRESSION; DISCOVERY;
D O I
10.1016/j.bmcl.2018.09.026
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dichloroacetophenone is a pyruvate dehydrogenase kinase 1 (PDK1) inhibitor with suboptimal kinase selectivity. Herein, we report the synthesis and biological evaluation of a series of novel dichloroacetophenones. Structure-activity relationship analyses (SARs) enabled us to identify three potent compounds, namely 54, 55, and 64, which inhibited PDK1 function, activated pyruvate dehydrogenase complex, and reduced the proliferation of NCI-H1975 cells. Mitochondrial bioenergetics assay suggested that 54, 55, and 64 enhanced the oxidative phosphorylation in cancer cells, which might contribute to the observed anti-proliferation effects. Collectively, these results suggested that 54, 55, and 64 could be promising compounds for the development of potent PDK1 inhibitors.
引用
收藏
页码:3441 / 3445
页数:5
相关论文
共 50 条
  • [21] Synthesis and structure-activity relationships of novel antiseptics
    Tsubouchi, H
    Ohguro, K
    Yasumura, K
    Ishikawa, H
    Kikuchi, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (13) : 1721 - 1724
  • [22] Synthesis and Structure-Activity Relationships of Skin Ceramides
    Novotny, J.
    Hrabalek, A.
    Vavrova, K.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (21) : 2301 - 2324
  • [23] Synthesis of tacrine analogues and their structure-activity relationships
    Proctor, GR
    Harvey, AL
    CURRENT MEDICINAL CHEMISTRY, 2000, 7 (03) : 295 - 302
  • [24] Butitaxel analogues: Synthesis and structure-activity relationships
    Ali, SM
    Hoemann, MZ
    Aube, J
    Georg, GI
    Mitscher, LA
    Jayasinghe, LR
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (02) : 236 - 241
  • [25] Quantitative Structure-Activity Relationship Modeling of Kinase Selectivity Profiles
    Kothiwale, Sandeepkumar
    Borza, Corina
    Pozzi, Ambra
    Meiler, Jens
    MOLECULES, 2017, 22 (09)
  • [26] Synthesis and structure-activity studies of simplified analogues of aplysiatoxin with antiproliferative activity like bryostatin-1
    Irie, Kazuhiro
    Kikumori, Masayuki
    Kamachi, Hiroaki
    Tanaka, Keisuke
    Murakami, Akira
    Yanagita, Ryo C.
    Tokuda, Harukuni
    Suzuki, Nobutaka
    Nagai, Hiroshi
    Suenaga, Kiyotake
    Nakagawa, Yu
    PURE AND APPLIED CHEMISTRY, 2012, 84 (06) : 1341 - 1351
  • [27] Synthesis and Structure-Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents
    Yadav, Veena D. D.
    Boshoff, Helena I. I.
    Trifonov, Lena
    Roma, Jose Santinni O.
    Ioerger, Thomas R. R.
    Barry, Clifton E. E.
    Oh, Sangmi
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (09): : 1275 - 1283
  • [28] Structure-activity and conformational-activity relationships of inhibitor of κB kinase-β
    Jones, Michael
    Wilson, Angela
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [29] Quantitative structure-activity relationships of cyclin-dependent kinase 1 inhibitors
    A. V. Zakharov
    A. A. Lagunin
    D. A. Filimonov
    V. V. Poroikov
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2007, 1 (1) : 17 - 28
  • [30] Quantitative Structure-Activity Relationships of Cyclin-Dependent Kinase 1 Inhibitors
    Zakharov, A. V.
    Lagunin, A. A.
    Filimonov, D. A.
    Poroikov, V. V.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2007, 1 (01) : 17 - 28